Abstract

The xerosis of the conjunctiva is a symptomatic condition in which the conjunctiva becomes dry, lusterless, and nonwettable. These patches almost always involve the interpalpebral area of the temporal quadrants and often nasal quadrants as well. Typical xerosis may be associated with conjunctival thickening, wrinkling, and pigmentation. Xerosis is correlated with Shuktika as the per Ayurvedic reference. In this disease, a small elevated blackish spot resembling shell appears in Shukla mandala. There are various noninvasive as well as safe treatment modalities mentioned in Ayurvedic classics for the treatment of Shuktika. Gambhari, Amalaki, and Haritaki Aschyotana are some of the medicines mentioned in Sushruta Samhita in the management of Shuktika. Hence, an attempt has been made in this regard to review the role of these drugs, i.e. topical instillation of Gambhari, Amalaki, and Haritaki eye drops in Shuktika. Ashchyotana is one among the seven Netra kriya kalpa. Gambhari, Amalaki, and Haritaki are found useful in treating Shuktika, i.e. conjunctival xerosis. As per Sushruta Samhita, the causative dosha in Shuktika is Pitta, and hence, the treatment involves in mitigating the Pitta dosha. It is told in Sushruta Samhita that the causative dosha should be eliminated. Gambhari, Amalaki, and Haritaki Ashchyotana have properties to eliminate Pitta dosha. The medicines mentioned in the present review are Pittahara and are considered best for the eyes. Gambhari, Amalaki, and Haritaki Ashchyotana are cost-effective, safe, and easy procedures which can be done by the patient himself/herself in their own homes.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.